EU Sanctions Sanofi's Dupixent For Smoker's lung's

Sanofi and Regeneron received European Union permission for the expanded use of their Dupixent injection in patients with chronic lung disease, a rare instance of the EU clearing a medicine faster than the United States. The EU Commission...

Sobi Commences Rolling BLA Application to US FDA For SEL-212

Sobi declared the commencement of a rolling Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for SEL-212. The pivotal studies DISSOLVE I and II served as the foundation for the submission. For the treatment of...

Kedrion Biopharma To Market Immunoglobulin therapy Yimmugo in US

Kedrion Biopharma Inc., a biopharmaceutical firm, declared that it has established the framework for a long-term partnership with Biotest AG for the complete commercialization and marketing of the immunoglobulin therapy Yimmugo in the United...

PharmAbcine Advances PMC-403 in Phase 1 Trials for nAMD Treatment

PharmAbcine, Inc, a clinical-stage firm developing next generation therapeutics to treat medical needs, declared the decision to accelerate PMC-403, its candidate treatment for neovascular age-related macular degeneration (nAMD), to the fourth...

Synaptogenix Receives US FDA Approval of IND Application

Synaptogenix, Inc., a growing biopharmaceutical firm developing therapies for neurodegenerative disorders, announced that the Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for Bryostatin-1...

Kerala govt to establish institute of organ transplantation in Kozhikode

The Government of Kerala has decided to establish an Institute of Organ and Tissue Transplant at Kozhikode. It is being established as an Apex Institute for research, training and patient care in the area of organ transplantation and allied

National Doctors Day: Honoring Contributions During Challenging Times

In India, the annual celebration of National Doctors Day honors and celebrates the significant contributions that physicians make to the lives of individuals and communities. It gives an opportunity to recognize the crucial efforts of doctors...

PLI Scheme To Bolster Domestic Manufacturing In India's Pharma Sector

India's Production Linked Incentive (PLI) program has prompted significant investments in the pharmaceutical industry with the intention of strengthening domestic manufacturing and decreasing import dependence, as per the data from the Department...

Surgence and Mayo Clinic Partner To innovate Healthcare Supply Chain

Surgence, a cloud-based digital platform developed by Concordance Innovations, a wholly owned subsidiary of Concordance Healthcare Solutions, has announced a collaboration with Mayo Clinic to integrate Surgence into their digital supply chain...

Orchid Pharma and Cipla Team To Unveil New Drug in India

Orchid Pharma Limited, a Chennai-based Indian pharmaceutical firm, has declared the availability of a new drug, cefepime-enmetazobactam, which has been endorsed for the treatment of complex urinary tract infections (cUTI), hospital-acquired...

© 2025 India Pharma Outlook. All Rights Reserved.